CM
TARS icon

Caption Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Caption Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Buy
+36,448
New +$2.55M 0.01% 751

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caption Management's TARS Position: Q1 2026 in Review

Caption Management opened a new position in Tarsus Pharmaceuticals (TARS) in Q1 2026: 36,448 shares worth $2.56M. The stake represents 0.01% of the portfolio and ranks #751 among its holdings.

253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Caption Management held 36,448 shares of Tarsus Pharmaceuticals worth $2.56M as of Q1 2026.
  • Tarsus Pharmaceuticals was a new Caption Management position in Q1 2026.
  • Tarsus Pharmaceuticals made up 0.01% of Caption Management's portfolio in Q1 2026, its #751 holding.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.